Related Experiment Video
Updated: Apr 23, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A straightforward guide to the sarcomeric basis of cardiomyopathies
Luís R Lopes1, Perry M Elliott2
1Institute of Cardiovascular Science, University College London, London, UK Centro de Cardiologia da Universidade de Lisboa, University of Lisbon, Lisbon, Portugal Cardiology Department, Hospital Garcia de Orta, Almada, Portugal.
Insights
Genetic mutations in sarcomeric proteins cause cardiomyopathies. Understanding sarcomere structure and function aids in identifying new gene targets and developing disease-modifying drugs for these muscle disorders.
Area of Science:
- Muscle physiology
- Cardiovascular genetics
- Molecular biology
Background:
- The sarcomere is the fundamental contractile unit in striated muscle.
- Mutations in sarcomeric protein genes lead to various cardiomyopathies, including hypertrophic, dilated, restrictive, and ventricular non-compaction.
- These genetic defects trigger diverse molecular pathways, affecting muscle function and leading to disease.
Purpose of the Study:
- To explore the link between sarcomeric protein mutations and cardiomyopathies.
- To understand the molecular mechanisms underlying disease phenotypes.
- To identify potential therapeutic targets for cardiomyopathy treatment.
Main Methods:
- Review of genetic studies on sarcomeric proteins.
- Analysis of molecular pathways affected by sarcomeric mutations.
- Investigation of structure-function relationships within the sarcomere.
Main Results:
- Sarcomeric protein gene mutations are a primary cause of diverse cardiomyopathies.
- Downstream effects include altered acto-myosin kinetics, mechanosensation, calcium handling, signaling, energetics, ischemia, and fibrosis.
- Genetic insights have improved understanding of sarcomere structure and function.
Conclusions:
- Elucidating genetic causes of cardiomyopathy enhances knowledge of sarcomere biology.
- Detailed understanding of sarcomeres and associated proteins suggests new candidate genes.
- Advances offer hope for developing novel disease-modifying drugs for cardiomyopathies.
Abstract:
The sarcomere is the principal contractile unit of striated muscle. Mutations in genes encoding sarcomeric proteins are responsible for a range of diseases including hypertrophic, dilated and restrictive cardiomyopathies and ventricular non-compaction. The downstream molecular pathways leading to these heterogeneous phenotypes include changes in acto-myosin cross-bridge kinetics, altered mechanosensation, disturbed calcium sensitivity, de-regulated signalling pathways, inefficient energetics, myocardial ischaemia and fibrosis. The elucidation of the genetic causes of cardiomyopathy has helped in understanding the structure and function of the sarcomere and a more detailed knowledge of the sarcomere and its associated proteins has suggested additional gene candidates. The new hope is that these advances will stimulate the discovery of disease-modifying drugs.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
The Sarcomere
Each...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

